CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 8 of 15

Osteoporosis International

Briefs 281–320 of 576 CurrentRheuma has covered from this journal, newest publication first

Latest from Osteoporosis International

All coverage, newest first

  1. Osteoporos Int

    Identifying rare variants in genes related to bone phenotypes in a cohort of postmenopausal women

    Cohort studyOsteoporosis

  2. Osteoporos Int

    Association between vertebral fractures and brain volume: insights from a community cohort study

    Cross-sectional studyOsteoporosis

  3. Osteoporos Int

    Ultra-processed food intake and prevalence of osteoporosis in US adults aged 50 years and older: a cross-sectional analysis

    Cross-sectional studyOsteoporosis

  4. Osteoporos Int

    Metaphyseal comminution in distal radius fractures: a predictor of secondary fragility fractures and the role of osteoporosis treatment

    Cohort studyOsteoporosis

  5. Osteoporos Int

    Time trend analysis of osteoporosis prevalence among adults 50 years of age and older in the USA, 2005–2018

    Cross-sectional studyOsteoporosis

  6. Osteoporos Int

    Impact of switching from bisphosphonates to denosumab, teriparatide, or romosozumab in patients with postmenopausal osteoporosis: a case–control study

    Case-control studyOsteoporosis

  7. Osteoporos Int

    A novel hybrid deep learning framework based on biplanar X-ray radiography images for bone density prediction and classification

    Diagnostic or prognostic studyOsteoporosis

  8. Osteoporos Int

    Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020

    Cohort studyOsteoporosis

  9. Osteoporos Int

    Effect of romosozumab on bone mineral density and trabecular bone score in premenopausal women with low bone mass

    Cohort studyOsteoporosis

  10. Osteoporos Int

    Fracture liaison service (FLS) is associated with lower subsequent fragility fracture risk and mortality: NoFRACT (the Norwegian capture the fracture initiative)

    Randomized controlled trialOsteoporosis

  11. Osteoporos Int

    Clinical experience with denosumab discontinuation

    Cohort studyOsteoporosis

  12. Osteoporos Int

    Is there an association between birth characteristics and fractures in young adults? The HUNT Study, Norway

    Cohort studyOsteoporosis

  13. Osteoporos Int

    Denosumab and clinical outcomes among men with osteoporosis: a retrospective cohort study

    Cohort studyOsteoporosis

  14. Osteoporos Int

    Cervicothoracic volumetric bone mineral density assessed by opportunistic QCT may be a reliable marker for osteoporosis in adults

    Diagnostic or prognostic studyOsteoporosis

  15. Osteoporos Int

    Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis

    Research articleOsteoporosis

  16. Osteoporos Int

    Osteoporotic fracture risks of thiazides and dihydropyridines in angiotensin modulator users

    Cohort studyOsteoporosis

  17. Osteoporos Int

    The impact of a fracture liaison service with in-hospital anti-osteoporosis treatment on subsequent hip fracture and mortality rates—a single-center retrospective study

    Cohort studyOsteoporosis

  18. Osteoporos Int

    Rationale for osteoporosis screening in men

    Guideline or statementOsteoporosis

  19. Osteoporos Int

    The effect of denosumab on minimum 3-years BMD changes in patients with osteoporotic hip fractures: a propensity score matching analysis

    Cohort studyOsteoporosis

  20. Osteoporos Int

    Impact of the guidance on fracture Liaison Services and the introduction of a new fee for secondary fracture prevention in Japan: Implementation of secondary fracture prevention during hospitalization for fragility fractures

    Cohort studyOsteoporosis

  21. Osteoporos Int

    Gut microbiome and bone health: update on mechanisms, clinical correlations, and possible treatment strategies

    Meta-analysisOsteoporosis

  22. Osteoporos Int

    Bisphosphonate drug holidays in osteoporosis according to fracture risk profile

    Cohort studyOsteoporosis

  23. Osteoporos Int

    Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005–2018

    Cross-sectional studyOsteoporosis

  24. Osteoporos Int

    Osteoporosis testing and treatment remain low in both Traditional Medicare and Medicare Advantage

    Cross-sectional studyOsteoporosis

  25. Osteoporos Int

    Osteoporosis in older patients with idiopathic normal pressure hydrocephalus

    Case-control studyOsteoporosis

  26. Osteoporos Int

    First fracture in rheumatoid arthritis: analysis by fracture site, gender, age, and comorbidities

    Cohort studyRA

  27. Osteoporos Int

    Systematic evaluation of abdominal aortic calcification in patients with a recent clinical fracture visiting the Fracture Liaison Service

    Cross-sectional studyOsteoporosis

  28. Osteoporos Int

    Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis

    Cohort studyOsteoporosis

  29. Osteoporos Int

    Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project

    Cross-sectional studyOsteoporosis

  30. Osteoporos Int

    Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan

    Cohort studyOsteoporosis

  31. Osteoporos Int

    Handgrip strength as a predictor of 1‑year mortality after hip fracture surgery in the Colombian Andes Mountains

    Cohort studyOsteoporosis

  32. Osteoporos Int

    Treatment for osteoporosis and risk of osteonecrosis of the jaw among female patients in the United Kingdom Clinical Practice Research Datalink

    Case-control studyOsteoporosis

  33. Osteoporos Int

    Regular physical activity improves physical function and health-related quality of life among middle-aged and older women who suffered a fragility fracture—a population-based cohort

    Cohort studyOsteoporosis

  34. Osteoporos Int

    Association between physical activity and mortality in patients with osteoporosis: a cohort study of NHANES

    Cohort studyOsteoporosis

  35. Osteoporos Int

    Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK

    Research articleOsteoporosis

  36. Osteoporos Int

    Association between renal function and fracture incidence during treatment with teriparatide or alendronate: an exploratory subgroup analysis of the Japanese Osteoporosis Intervention Trial-05

    Secondary analysisOsteoporosis

  37. Osteoporos Int

    Among people on osteoporosis medication, loss of appendicular or total body lean mass is an independent risk factor for hip and major osteoporotic fractures

    Cohort studyOsteoporosis

  38. Osteoporos Int

    Comparative effectiveness and cardiovascular safety of romosozumab versus teriparatide in patients with osteoporosis: a population-based cohort study

    Cohort studyOsteoporosis

  39. Osteoporos Int

    Exposure to air pollution might decrease bone mineral density and increase the prevalence of osteoporosis: a Mendelian randomization study

    Research articleOsteoporosis

  40. Osteoporos Int

    The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy

    Cohort studyOsteoporosis

All 576 Briefs in ExploreShowing Briefs 281–320 of 576, newest first